Document is current
Any future updates will be listed below
-
Authors
Saei, Amir Ata https://orcid.org/0000-0002-2639-6328
Beusch, Christian Michel https://orcid.org/0000-0001-9100-8283
Chernobrovkin, Alexey https://orcid.org/0000-0001-7709-0161
Sabatier, Pierre https://orcid.org/0000-0002-2734-1791
Zhang, Bo https://orcid.org/0000-0001-8890-8416
Tokat, Ülkü Güler
Stergiou, Eleni https://orcid.org/0000-0001-9115-4985
Gaetani, Massimiliano https://orcid.org/0000-0001-5610-0797
Végvári, Ákos https://orcid.org/0000-0002-1287-0906
Zubarev, Roman A.
-
Funding
Funding for this research was provided by:
Cancerfonden (2016/546, 2017/1081)
- License Information
-
More Information
Article History
Received: 12 April 2019
Accepted: 11 November 2019
First Online: 16 December 2019
Competing interests
: B.Z. is currently an employee of AstraZeneca. Alexey Chernobrovkin is currently an employee of Pelago Bioscience AB. The other authors declare no potential conflicts of interest.
